Scott D'amour Named As Chief Financial Officer of Biocoat, Replaces the Retiring Steve Bell
11/14/23, 2:23 PM
Location
horshamIndustry
medical
biotechnology
manufacturing
medical device
health care
Position
chief financial officer
Biocoat Incorporated, a specialty manufacturer of hydrophilic biomaterial coatings and coating equipment for medical devices, announced the addition of Scott D'Amour as the new Chief Financial Officer. Mr. D'Amour is replacing Steve Bell who has held this position since 2019.
Steve Bell has served as the Chief Financial Officer of Biocoat since January 2019 and will be retiring in November 2023.
Company Info
Location
horsham, pennsylvania, united states
Additional Info
Biocoat Incorporated develops and licenses biomaterial coatings for medical devices that are custom engineered to meet client design parameters. Its specialty is supplying lubricious hydrophilic coatings for medical devices. Our full-service coating solution includes industry-leading coating performance, high-touch customer service, and dip coating equipment that is specifically designed to maximize the coating process.